Imagion Biosystems Ltd (IBX) - Net Assets

Latest as of December 2025: AU$-2.16 Million AUD ≈ $-1.53 Million USD

Based on the latest financial reports, Imagion Biosystems Ltd (IBX) has net assets worth AU$-2.16 Million AUD (≈ $-1.53 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$2.04 Million ≈ $1.45 Million USD) and total liabilities (AU$4.21 Million ≈ $2.98 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore total assets of Imagion Biosystems Ltd for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$-2.16 Million
% of Total Assets -105.76%
Annual Growth Rate N/A
5-Year Change -116.25%
10-Year Change -118.49%
Growth Volatility 147.76

Imagion Biosystems Ltd - Net Assets Trend (2014–2025)

This chart illustrates how Imagion Biosystems Ltd's net assets have evolved over time, based on quarterly financial data. Check IBX tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Imagion Biosystems Ltd (2014–2025)

The table below shows the annual net assets of Imagion Biosystems Ltd from 2014 to 2025. For live valuation and market cap data, see IBX market cap overview.

Year Net Assets Change
2025-12-31 AU$-2.16 Million
≈ $-1.53 Million		 +5.30%
2024-12-31 AU$-2.28 Million
≈ $-1.62 Million		 +39.73%
2023-12-31 AU$-3.79 Million
≈ $-2.68 Million		 -180.98%
2022-12-31 AU$4.68 Million
≈ $3.31 Million		 -64.84%
2021-12-31 AU$13.31 Million
≈ $9.41 Million		 +3.03%
2020-12-31 AU$12.91 Million
≈ $9.14 Million		 +334.30%
2019-12-31 AU$2.97 Million
≈ $2.10 Million		 -23.15%
2018-12-31 AU$3.87 Million
≈ $2.74 Million		 -44.35%
2017-12-31 AU$6.95 Million
≈ $4.92 Million		 -40.52%
2016-12-31 AU$11.69 Million
≈ $8.27 Million		 +231.88%
2015-12-31 AU$-8.86 Million
≈ $-6.27 Million		 -123.17%
2014-12-31 AU$-3.97 Million
≈ $-2.81 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Imagion Biosystems Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 6727701400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock AU$65.96 Million %
Other Comprehensive Income AU$3.20 Million %
Other Components AU$1.00 %
Total Equity AU$-2.16 Million 100.00%

Imagion Biosystems Ltd Competitors by Market Cap

The table below lists competitors of Imagion Biosystems Ltd ranked by their market capitalization.

Company Market Cap
Click Holdings Limited
NASDAQ:CLIK
 $4.17 Million
Sulliden Minerals SA
TO:SMC
 $4.17 Million
Zeb Nickel Corp
V:ZBNI
 $4.17 Million
TAIZHOU WATER GRP. H YC 1
F:GX5
 $4.18 Million
FATHOM NICKEL INC.
F:6Q5
 $4.16 Million
Lion Energy Ltd
AU:LIO
 $4.16 Million
Danasupra Erapacific Tbk
JK:DEFI
 $4.16 Million
Rare Earth Magnesium Technology Group Holdings Limited
STU:GPS
 $4.16 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Imagion Biosystems Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -2,282,980 to -2,161,917, a change of 121,063.
  • Net loss of 4,309,456 reduced equity.
  • Share repurchases of 257,518 reduced equity.
  • New share issuances of 3,500,263 increased equity.
  • Other comprehensive income increased equity by 1,016,968.
  • Other factors increased equity by 170,806.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-4.31 Million -199.33%
Share Repurchases AU$257.52K -11.91%
Share Issuances AU$3.50 Million +161.91%
Other Comprehensive Income AU$1.02 Million +47.04%
Other Changes AU$170.81K +7.9%
Total Change AU$- %

Book Value vs Market Value Analysis

This analysis compares Imagion Biosystems Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2014-12-31 AU$-193.74 AU$0.01 x
2015-12-31 AU$-432.37 AU$0.01 x
2016-12-31 AU$0.11 AU$0.01 x
2017-12-31 AU$0.04 AU$0.01 x
2018-12-31 AU$0.02 AU$0.01 x
2019-12-31 AU$0.33 AU$0.01 x
2020-12-31 AU$0.69 AU$0.01 x
2021-12-31 AU$0.51 AU$0.01 x
2022-12-31 AU$0.17 AU$0.01 x
2023-12-31 AU$-0.12 AU$0.01 x
2024-12-31 AU$-0.05 AU$0.01 x
2025-12-31 AU$-0.01 AU$0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Imagion Biosystems Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -13313.12%
  • • Asset Turnover: 0.02x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-62.39%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2014 0.00% -41159.99% 0.02x 0.00x AU$-2.12 Million
2015 0.00% -80124.99% 0.01x 0.00x AU$-3.51 Million
2016 -8.85% -8620641.67% 0.00x 1.04x AU$-2.20 Million
2017 -112.11% -38775.26% 0.00x 1.10x AU$-8.49 Million
2018 -215.75% -4359.67% 0.04x 1.34x AU$-8.73 Million
2019 -115.44% -835.46% 0.08x 1.64x AU$-3.73 Million
2020 -41.54% -2607.47% 0.01x 1.09x AU$-6.66 Million
2021 -45.28% -2587.21% 0.02x 1.06x AU$-7.36 Million
2022 -209.71% -2071.95% 0.05x 2.13x AU$-10.28 Million
2023 0.00% -1151.86% 0.24x 0.00x AU$-12.10 Million
2024 0.00% -77.56% 0.95x 0.00x AU$-1.84 Million
2025 0.00% -13313.12% 0.02x 0.00x AU$-4.09 Million

Industry Comparison

This section compares Imagion Biosystems Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

  • Industry: Diagnostics & Research
  • Average net assets among peers: $256,363,532
  • Average return on equity (ROE) among peers: -8.48%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Imagion Biosystems Ltd (IBX) AU$-2.16 Million 0.00% N/A $4.17 Million
Australian Clinical Labs Ltd (ACL) $177.76 Million 13.46% 2.34x $316.04 Million
Bcal Diagnostics Ltd (BDX) $9.64 Million -35.12% 0.10x $17.48 Million
Cryosite Ltd (CTE) $4.69 Million 7.13% 0.84x $41.44 Million
Genetic Signatures Ltd (GSS) $7.06 Million -37.68% 0.11x $9.48 Million
Genetic Technologies Ltd (GTG) $38.07 Million -8.91% 0.04x $4.01 Million
Healius Ltd (HLS) $1.92 Billion 16.02% 1.15x $192.68 Million
Integral Diagnostics Ltd (IDX) $90.35 Million 17.13% 1.11x $554.13 Million
Inoviq Ltd (IIQ) $16.88 Million 0.01% 0.03x $19.42 Million
Microba Life Sciences Ltd (MAP) $41.22 Million -48.38% 0.41x $20.68 Million

About Imagion Biosystems Ltd

AU:IBX Australia Diagnostics & Research
Market Cap
$4.17 Million
AU$5.89 Million AUD
Market Cap Rank
#28888 Global
#1574 in Australia
Share Price
AU$0.01
Change (1 day)
-7.69%
52-Week Range
AU$0.01 - AU$0.05
All Time High
AU$8.60
Categories
Companies in Australia Diagnostics & Research
About

Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing th… Read more